"neoadjuvant chemotherapy" trang 8 - tải miễn phí từ tailieunhanh
Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands

Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands
17    34    1
The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients

The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients
8    51    1
Texture analysis on MR images helps predicting non-response to NAC in breast cancer

Texture analysis on MR images helps predicting non-response to NAC in breast cancer
13    25    1
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes

Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes
10    30    1
Quantitative measurements of HER2 and phospho-HER2 expression: Correlation with pathologic response to neoadjuvant chemotherapy and trastuzumab

Quantitative measurements of HER2 and phospho-HER2 expression: Correlation with pathologic response to neoadjuvant chemotherapy and trastuzumab
8    42    1
Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: Results from a subgroup analysis of a prospective trial

Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: Results from a subgroup analysis of a prospective trial
12    47    1
Carbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline

Carbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline
10    38    1
Postoperative nomogram to predict the probability of metastasis in Enneking stage IIB extremity osteosarcoma

Postoperative nomogram to predict the probability of metastasis in Enneking stage IIB extremity osteosarcoma
10    46    1
Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer

Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer
9    45    1
Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2)

Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2)
7    62    1
Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5- fluorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC)

Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5- fluorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC)
11    28    1
Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: A Bayesian network meta-analysis

Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: A Bayesian network meta-analysis
13    54    1
Real-world management and outcomes of older patients with locally advanced esophageal squamous cell carcinoma: A multicenter retrospective study

Real-world management and outcomes of older patients with locally advanced esophageal squamous cell carcinoma: A multicenter retrospective study
11    2    1
FAP, CD10, and GPR77-labeled CAFs cause neoadjuvant chemotherapy resistance by inducing EMT and CSC in gastric cancer

FAP, CD10, and GPR77-labeled CAFs cause neoadjuvant chemotherapy resistance by inducing EMT and CSC in gastric cancer
15    7    1
Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)

Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
7    1    1
Prognostic value of a modified systemic inflammation score in breast cancer patients who underwent neoadjuvant chemotherapy

Prognostic value of a modified systemic inflammation score in breast cancer patients who underwent neoadjuvant chemotherapy
15    1    1
A new model of preoperative systemic inflammatory markers predicting overall survival of osteosarcoma: A multicenter retrospective study

A new model of preoperative systemic inflammatory markers predicting overall survival of osteosarcoma: A multicenter retrospective study
9    2    1
Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma

Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma
10    90    0
A novel detection methodology for HER2 protein quantitation in formalin-fixed, paraffin embedded clinical samples using fluorescent nanoparticles: An analytical and clinical validation study

A novel detection methodology for HER2 protein quantitation in formalin-fixed, paraffin embedded clinical samples using fluorescent nanoparticles: An analytical and clinical validation study
15    70    1
Predictive value of lymphocyte-tomonocyte ratio in the preoperative setting for progression of patients with breast cancer

Predictive value of lymphocyte-tomonocyte ratio in the preoperative setting for progression of patients with breast cancer
9    32    1